Detection of BRAFV600E in Liquid Biopsy from Patients with Papillary Thyroid Cancer Is Associated with Tumor Aggressiveness and Response to Therapy

The detection of rare mutational targets in plasma (liquid biopsy) has emerged as a promising tool for the assessment of patients with cancer. We determined the presence of cell-free DNA containing the BRAFV600E mutations (cfBRAFV600E) in plasma samples from 57 patients with papillary thyroid cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Jensen, Kirk, Thakur, Shilpa, Patel, Aneeta, Mendonca-Torres, Maria Cecilia, Costello, John, Gomes-Lima, Cristiane Jeyce, Walter, Mary, Wartofsky, Leonard, Burman, Kenneth Dale, Bikas, Athanasios, Ylli, Dorina, Vasko, Vasyl V., Klubo-Gwiezdzinska, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464493/
https://www.ncbi.nlm.nih.gov/pubmed/32748840
http://dx.doi.org/10.3390/jcm9082481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464493/
https://www.ncbi.nlm.nih.gov/pubmed/32748840
http://dx.doi.org/10.3390/jcm9082481

Ejemplares similares